Acute onset of rheumatoid arthritis associated with administration of a dipeptidyl peptidase-4 (DPP-4) inhibitor to patients with diabetes mellitus

Diabetology International

Volumn 1, Issue 2, 2010, Pages 90-92

  Sasaki, Takashi ^a,b   Hiki, Yoshito ^a,b   Nagumo, Sae ^a   Ikeda, Rina ^a   Kimura, Haruka ^a   Yamashiro, Kenji ^a   Gojo, Atsushi ^a   Saito, Tatsuhiko ^c   Tomita, Yasuyuki ^a   Utsunomiya, Kazunori ^b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Kobari General Hospital   (Japan)

Author keywords

Adverse event; Chemokine; DPP 4; Incretin; Oral hypoglycemic agent; Stromal cell derived factor 1

Indexed keywords

C REACTIVE PROTEIN; CREATININE; GLIMEPIRIDE; GLUCOSE; GLUTAMATE DECARBOXYLASE ANTIBODY; INSULIN; SALAZOSULFAPYRIDINE; SITAGLIPTIN;

ADULT; ARTHRALGIA; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN TREATMENT; KNEE; LABORATORY TEST; MALE; METACARPAL BONE; METATARSOPHALANGEAL JOINT; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROXIMAL INTERPHALANGEAL JOINT; RHEUMATOID ARTHRITIS; SWELLING; TREATMENT DURATION; WRIST;

EID: 84862859099     PISSN: 21901678     EISSN: 21901686     Source Type: Journal    
DOI: 10.1007/s13340-010-0010-y     Document Type: Article

References (8)

1. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 1996; 184: 1101-9.
2. Drucker DJ. Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action. Diabetes Care. 2007; 30: 1335-43.
3. Busso N, Wagtmann N, Herling C, Chobaz-Péclat V, Bischof-Delaloye A, So A, Grouzmann E. Circulating CD26 is negatively associated with inflammation in human and experimental arthritis. Am J Pathol. 2005; 166: 433-42.
4. Ospelt C, Mertens JC, Jüngel A, Brentano F, Maciejewska-Rodriguez H, Huber LC, Hemmatazad H, Wüest T, Knuth A, Gay RE, Michel BA, Gay S, Renner C, Bauer S. Inhibition of fibroblast activation protein and dipeptidylpeptidase 4 increases cartilage invasion by rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 2010; 62: 1224-35.
5. Kamori M, Hagihara M, Nagatsu T, Iwata H, Miura T. Activities of dipeptidyl peptidase II, dipeptidyl peptidase IV prolyl endopeptidase, and collagenase-like peptidase in synovial membrane from patients with rheumatoid arthritis and osteoarthritis. Biochem Med Metab Biol. 1991; 45: 154-60.
6. Williams-Herman D, Engel SS, Round E, Johnson J, Golm GT, Guo H, Musser BJ, Davies MJ, Kaufman KD, Goldstein BJ. Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10, 246 patients with type 2 diabetes. BMC Endocr Disord. 2010; 10: 7. doi: 10. 1186/1472-6823-10-7.
7. http://januvia. jp/secure/index. html.
8. The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc. 2010; 53: 450-67.